{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:33:23Z","timestamp":1790184803603,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-024-08476-0","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T13:03:08Z","timestamp":1727960588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of a pharmacist care protocol to manage uncomplicated female cystitis in community pharmacies: an open-label, multicenter, randomized, controlled, cluster study: the PharmaCyst\u2019 protocol"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6348-4717","authenticated-orcid":false,"given":"Arthur","family":"Piraux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Parot-Schinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Hamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Naber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Claire","family":"Oger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Guilleminot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Ramond-Roquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Faure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"key":"8476_CR1","doi-asserted-by":"publisher","unstructured":"Geerlings SE. Clinical presentations and epidemiology of urinary tract infections. Microbiol Spectr. 2016;4(5). https:\/\/doi.org\/10.1128\/microbiolspec.UTI-0002-2012.","DOI":"10.1128\/microbiolspec.UTI-0002-2012"},{"issue":"8","key":"8476_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S1047-2797(00)00072-7","volume":"10","author":"B Foxman","year":"2000","unstructured":"Foxman B, Barlow R, D\u2019Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10(8):509\u201315.","journal-title":"Ann Epidemiol"},{"issue":"114","key":"8476_CR3","first-page":"10","volume":"25","author":"L Letrilliart","year":"2014","unstructured":"Letrilliart L, Supper I, Schuers M, Darmon D, Boulet P, Favre M, et al. ECOGEN: \u00e9tude des el\u00e9ments de la COnsultation en m\u00e9decine GEN\u00e9rale. Exercer. 2014;25(114):10 Available from: https:\/\/hal.science\/hal-02046833.","journal-title":"Exercer"},{"issue":"4","key":"8476_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S1294-5501(04)94270-7","volume":"6","author":"P Le Conte","year":"2004","unstructured":"Le Conte P, Elkharrat D, Potel G. Prise en charge des infections urinaires communautaires dans les Service d\u2019Accueil et d\u2019Urgence Fran\u00e7ais. Antibiotiques. 2004;6(4):237\u20139.","journal-title":"Antibiotiques"},{"issue":"5","key":"8476_CR5","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for microbiology and infectious diseases. Clin Infect Dis. 2011;52(5):e103\u201320.","journal-title":"Clin Infect Dis"},{"key":"8476_CR6","unstructured":"Haute autorit\u00e9 Sant\u00e9. Cystite aigu\u00eb simple, \u00e0 risque de complication ou r\u00e9cidivante, de la femme. 2021. Available from: https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2021-08\/fiche_memo_cystite_durees_antibiotherapies_.pdf. Cited 2021 Oct 10."},{"issue":"1","key":"8476_CR7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/s12879-016-1888-1","volume":"16","author":"PC Matthews","year":"2016","unstructured":"Matthews PC, Barrett LK, Warren S, Stoesser N, Snelling M, Scarborough M, et al. Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study. BMC Infect Dis. 2016;16(1):556.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"8476_CR8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1186\/s12913-021-06653-4","volume":"21","author":"A Piraux","year":"2021","unstructured":"Piraux A, Faure S, Naber KG, Alidjanov JF, Ramond-Roquin A. Changes in the management of urinary tract infections in women: impact of the new recommendations on antibiotic prescribing behavior in France, between 2014 and 2019. BMC Health Serv Res. 2021;21(1):612.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"8476_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/00325481.2019.1680052","volume":"132","author":"MS Bader","year":"2020","unstructured":"Bader MS, Loeb M, Leto D, Brooks AA. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. Postgrad Med. 2020;132(3):234\u201350.","journal-title":"Postgrad Med"},{"issue":"9","key":"8476_CR10","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s10198-020-01222-8","volume":"21","author":"J Silhol","year":"2020","unstructured":"Silhol J, Ventelou B, Zaytseva A. How French general practitioners respond to declining medical density: a study on prescription practices, with an insight into opioids use. Eur J Health Econ. 2020;21(9):1391\u20138.","journal-title":"Eur J Health Econ"},{"key":"8476_CR11","first-page":"121","volume":"2\u20133","author":"L Hartmann","year":"2006","unstructured":"Hartmann L, Ulmann P, Rochaix L. L\u2019acc\u00e8s aux soins de premier recours en Europe. \u00c9l\u00e9ments de pr\u00e9sentation. Rev Fr Aff Soc. 2006;2\u20133:121\u201339.","journal-title":"Rev Fr Aff Soc."},{"key":"8476_CR12","unstructured":"Ordre national des pharmaciens. D\u00e9mographie des pharmaciens - Panorama au 1er janvier 2022. p. 144. Available from: https:\/\/www.ordre.pharmacien.fr\/les-communications\/focus-sur\/les-autres-publications\/demographie-des-pharmaciens-panorama-au-1er-janvier-2023. Cited 2023 Jul 30."},{"issue":"4","key":"8476_CR13","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.sapharm.2015.08.010","volume":"12","author":"P Erni","year":"2016","unstructured":"Erni P, von Overbeck J, Reich O, Ruggli M. netCare, a new collaborative primary health care service based in Swiss community pharmacies. Res Soc Adm Pharm. 2016;12(4):622\u20136.","journal-title":"Res Soc Adm Pharm"},{"issue":"6","key":"8476_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1017\/S1463423617000925","volume":"19","author":"F Stewart","year":"2018","unstructured":"Stewart F, Caldwell G, Cassells K, Burton J, Watson A. Building capacity in primary care: the implementation of a novel \u2018Pharmacy First\u2019 scheme for the management of UTI, impetigo and COPD exacerbation. Prim Health Care Res Dev. 2018;19(6):531\u201341.","journal-title":"Prim Health Care Res Dev"},{"issue":"1","key":"8476_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sapharm.2016.01.002","volume":"13","author":"IM Famiyeh","year":"2017","unstructured":"Famiyeh IM, McCarthy L. Pharmacist prescribing: a scoping review about the views and experiences of patients and the public. Res Soc Adm Pharm. 2017;13(1):1\u201316.","journal-title":"Res Soc Adm Pharm"},{"issue":"609","key":"8476_CR16","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.3399\/bjgp13X665206","volume":"63","author":"JL Booth","year":"2013","unstructured":"Booth JL, Mullen AB, Thomson DA, Johnstone C, Galbraith SJ, Bryson SM, et al. Antibiotic treatment of urinary tract infection by community pharmacists: a cross-sectional study. Br J Gen Pract. 2013;63(609):e244\u20139.","journal-title":"Br J Gen Pract"},{"issue":"5","key":"8476_CR17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.2042-7174.2011.00130.x","volume":"19","author":"DC Stewart","year":"2011","unstructured":"Stewart DC, MacLure K, Bond CM, Cunningham S, Diack L, George J, et al. Pharmacist prescribing in primary care: the views of patients across Great Britain who had experienced the service. Int J Pharm Pract. 2011;19(5):328\u201332.","journal-title":"Int J Pharm Pract"},{"issue":"2","key":"8476_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/ijpp.12128","volume":"23","author":"K Mansell","year":"2015","unstructured":"Mansell K, Bootsman N, Kuntz A, Taylor J. Evaluating pharmacist prescribing for minor ailments. Int J Pharm Pract. 2015;23(2):95\u2013101.","journal-title":"Int J Pharm Pract"},{"key":"8476_CR19","unstructured":"Arr\u00eat\u00e9 du 6 mars 2020 relatif \u00e0 l\u2019autorisation du protocole de coop\u00e9ration \u00abPrise en charge de la pollakiurie et de la br\u00fblure mictionnelle chez la femme de 16 \u00e0 65 ans par l\u2019infirmier dipl\u00f4m\u00e9 d\u2019Etat et le pharmacien d\u2019officine dans le cadre d\u2019une structure pluri-professionnelle\u00bb. Code de la sant\u00e9 publique, NOR: SSAH2006770A Mar 6, 2020. Available from: https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000041697967."},{"key":"8476_CR20","unstructured":"Bey L. Cr\u00e9ation d\u2019une fiche d\u2019information pour les patientes souffrant de cystites r\u00e9cidivantes: \u00e9tude qualitative de leurs besoins et attentes. 2018; Available from: https:\/\/dumas.ccsd.cnrs.fr\/dumas-02146591\/document."},{"issue":"5","key":"8476_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/1715163518781175","volume":"151","author":"NP Beahm","year":"2018","unstructured":"Beahm NP, Smyth DJ, Tsuyuki RT. Outcomes of urinary tract infection management by pharmacists (RxOUTMAP): a study of pharmacist prescribing and care in patients with uncomplicated urinary tract infections in the community. Can Pharm J (Ott). 2018;151(5):305\u201314. https:\/\/doi.org\/10.1177\/1715163518781175.","journal-title":"Can Pharm J (Ott)"},{"issue":"4","key":"8476_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1159\/000448591","volume":"97","author":"JF Alidjanov","year":"2016","unstructured":"Alidjanov JF, Abdufattaev UA, Makhsudov SA, Pilatz A, Akilov FA, Naber KG, et al. The acute cystitis symptom score for patient-reported outcome assessment. Urol Int. 2016;97(4):402\u20139.","journal-title":"Urol Int"},{"issue":"8","key":"8476_CR23","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s00345-019-02948-8","volume":"38","author":"JF Alidjanov","year":"2020","unstructured":"Alidjanov JF, Naber KG, Pilatz A, Radzhabov A, Zamuddinov M, Magyar A, Tenke P, Wagenlehner FM. Additional assessment of acute cystitis symptom score questionnaire for patient-reported outcome measure in female patients with acute uncomplicated cystitis: part II. World J Urol. 2020;38(8):1977\u201388. https:\/\/doi.org\/10.1007\/s00345-019-02948-8.","journal-title":"World J Urol"},{"issue":"2","key":"8476_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.purol.2021.12.001","volume":"32","author":"F Bruy\u00e8re","year":"2022","unstructured":"Bruy\u00e8re F, Piraux A, Bohbot JM, Begue C, Vall\u00e9e M, Alidjanov J, Pilatz A, Naber KG, Wagenlehner FME. Linguistic validation and cognitive assessment of the French version of the acute cystitis symptom score questionnaire. Prog Urol. 2022;32(2):73\u20136. https:\/\/doi.org\/10.1016\/j.purol.2021.12.001.","journal-title":"Prog Urol"},{"issue":"8","key":"8476_CR25","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jclinepi.2003.12.013","volume":"57","author":"G Adams","year":"2004","unstructured":"Adams G, Gulliford MC, Ukoumunne OC, Eldridge S, Chinn S, Campbell MJ. Patterns of intra-cluster correlation from primary care research to inform study design and analysis. J Clin Epidemiol. 2004;57(8):785\u201394.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"8476_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000493368","volume":"101","author":"FM Wagenlehner","year":"2018","unstructured":"Wagenlehner FM, Abramov-Sommariva D, H\u00f6ller M, Steindl H, Naber KG. Non-antibiotic herbal therapy (BNO 1045) versus antibiotic therapy (fosfomycin trometamol) for the treatment of acute lower uncomplicated urinary tract infections in women: a double-blind, parallel-group, randomized, multicentre, non-inferiority phase III trial. Urol Int. 2018;101(3):327\u201336.","journal-title":"Urol Int"},{"key":"8476_CR27","unstructured":"ORS (Observatoire r\u00e9gional de la sant\u00e9). D\u00e9mographie des m\u00e9decins en Pays de la Loire: g\u00e9n\u00e9ralistes. Situation 2018 et \u00e9volution. Pays de la Loire: Observatoire r\u00e9gional de la sant\u00e9; 2019. p. 4. (La sant\u00e9 observ\u00e9e). Report No.: 8. Available from: https:\/\/www.santepaysdelaloire.com\/ors\/sites\/ors\/files\/publications\/LSO_Demographie_Prof\/2019_8_med_spe_generalistes.pdf. Cited 2020 Apr 26."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08476-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-024-08476-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08476-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T13:05:26Z","timestamp":1727960726000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-024-08476-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8476"],"URL":"https:\/\/doi.org\/10.1186\/s13063-024-08476-0","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,3]]},"assertion":[{"value":"23 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol received approval from the French ethics committee \u201cComit\u00e9 de protection des personnes Ile de France VII, France\u201d (n\u00b0-2022-A01874-39 on 2nd December 2022) and of the French \"Commission Nationale de l'Informatique et des Libert\u00e9s\" (Data Protection Authority) for centralized monitoring (on 6th June 2023). The trial is conducted in compliance with French law no. 2012-300 of 12 March 2012 relative to the research involving the human person and following Good Clinical Practice (I.C.H. E6(R2)), the Public Health Code of Ethics, and the Helsinki Declaration (Ethical Principles for Medical Research involving Human Subjects, Tokyo 2004) and other requirements as appropriate. Free and informed consent will be requested before each inclusion.The study is registered on an open access website (ClinicalTrials.gov) under the number 49RC22_0240.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable - no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"654"}}